CN113646308B - 钆和基于非对映异构体富集的pcta的螯合配体的络合物及其制备和纯化方法 - Google Patents

钆和基于非对映异构体富集的pcta的螯合配体的络合物及其制备和纯化方法 Download PDF

Info

Publication number
CN113646308B
CN113646308B CN202080009625.8A CN202080009625A CN113646308B CN 113646308 B CN113646308 B CN 113646308B CN 202080009625 A CN202080009625 A CN 202080009625A CN 113646308 B CN113646308 B CN 113646308B
Authority
CN
China
Prior art keywords
formula
complex
rrr
sss
gadolinium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202080009625.8A
Other languages
English (en)
Chinese (zh)
Other versions
CN113646308A (zh
Inventor
斯瓦兹克·格雷纽
艾伦·切内德
马丁尼·瑟夫
米里亚姆·佩塔
艾曼纽尔·马拉斯
布鲁诺·弗朗索瓦
卡罗琳·罗比克
斯蒂芬妮·卢盖
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fa Guojiabai
Original Assignee
Fa Guojiabai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fa Guojiabai filed Critical Fa Guojiabai
Priority to CN202411689939.3A priority Critical patent/CN119552163A/zh
Priority to CN202111049738.3A priority patent/CN113735854B/zh
Publication of CN113646308A publication Critical patent/CN113646308A/zh
Application granted granted Critical
Publication of CN113646308B publication Critical patent/CN113646308B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN202080009625.8A 2019-01-17 2020-01-17 钆和基于非对映异构体富集的pcta的螯合配体的络合物及其制备和纯化方法 Active CN113646308B (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202411689939.3A CN119552163A (zh) 2019-01-17 2020-01-17 钆和基于非对映异构体富集的pcta的螯合配体的络合物及其制备和纯化方法
CN202111049738.3A CN113735854B (zh) 2019-01-17 2020-01-17 钆和基于非对映异构体富集的pcta的螯合配体的络合物及其制备和纯化方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1900432A FR3091873B1 (fr) 2019-01-17 2019-01-17 Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
FR1900432 2019-01-17
PCT/EP2020/051153 WO2020148436A1 (fr) 2019-01-17 2020-01-17 Complexe de gadolinium et d'un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification

Related Child Applications (2)

Application Number Title Priority Date Filing Date
CN202411689939.3A Division CN119552163A (zh) 2019-01-17 2020-01-17 钆和基于非对映异构体富集的pcta的螯合配体的络合物及其制备和纯化方法
CN202111049738.3A Division CN113735854B (zh) 2019-01-17 2020-01-17 钆和基于非对映异构体富集的pcta的螯合配体的络合物及其制备和纯化方法

Publications (2)

Publication Number Publication Date
CN113646308A CN113646308A (zh) 2021-11-12
CN113646308B true CN113646308B (zh) 2024-12-13

Family

ID=67001953

Family Applications (3)

Application Number Title Priority Date Filing Date
CN202080009625.8A Active CN113646308B (zh) 2019-01-17 2020-01-17 钆和基于非对映异构体富集的pcta的螯合配体的络合物及其制备和纯化方法
CN202411689939.3A Pending CN119552163A (zh) 2019-01-17 2020-01-17 钆和基于非对映异构体富集的pcta的螯合配体的络合物及其制备和纯化方法
CN202111049738.3A Active CN113735854B (zh) 2019-01-17 2020-01-17 钆和基于非对映异构体富集的pcta的螯合配体的络合物及其制备和纯化方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN202411689939.3A Pending CN119552163A (zh) 2019-01-17 2020-01-17 钆和基于非对映异构体富集的pcta的螯合配体的络合物及其制备和纯化方法
CN202111049738.3A Active CN113735854B (zh) 2019-01-17 2020-01-17 钆和基于非对映异构体富集的pcta的螯合配体的络合物及其制备和纯化方法

Country Status (28)

Country Link
US (3) US11590246B2 (cg-RX-API-DMAC7.html)
EP (2) EP3902800B1 (cg-RX-API-DMAC7.html)
JP (2) JP7071596B2 (cg-RX-API-DMAC7.html)
KR (2) KR102502862B1 (cg-RX-API-DMAC7.html)
CN (3) CN113646308B (cg-RX-API-DMAC7.html)
AR (1) AR117835A1 (cg-RX-API-DMAC7.html)
AU (1) AU2020208794B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021014006B1 (cg-RX-API-DMAC7.html)
CA (1) CA3126268C (cg-RX-API-DMAC7.html)
CL (1) CL2021001868A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021009261A2 (cg-RX-API-DMAC7.html)
DK (2) DK3943493T3 (cg-RX-API-DMAC7.html)
ES (2) ES2930136T3 (cg-RX-API-DMAC7.html)
FI (1) FI3943493T3 (cg-RX-API-DMAC7.html)
FR (1) FR3091873B1 (cg-RX-API-DMAC7.html)
HR (2) HRP20221402T1 (cg-RX-API-DMAC7.html)
HU (2) HUE062554T2 (cg-RX-API-DMAC7.html)
IL (1) IL284884B2 (cg-RX-API-DMAC7.html)
MA (2) MA55389A (cg-RX-API-DMAC7.html)
MX (1) MX2021008651A (cg-RX-API-DMAC7.html)
PH (1) PH12021551725A1 (cg-RX-API-DMAC7.html)
PL (2) PL3943493T3 (cg-RX-API-DMAC7.html)
PT (2) PT3902800T (cg-RX-API-DMAC7.html)
RS (1) RS64334B1 (cg-RX-API-DMAC7.html)
SG (1) SG11202107779SA (cg-RX-API-DMAC7.html)
TW (1) TWI811518B (cg-RX-API-DMAC7.html)
WO (1) WO2020148436A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202104994B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020030618A1 (en) 2018-08-06 2020-02-13 Bracco Imaging Spa Gadolinium bearing pcta-based contrast agents
FR3091873B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
FR3091872B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese
US20230339945A1 (en) * 2020-07-17 2023-10-26 Guerbet Method for preparing a chelating ligand derived from pcta
EP4222861A4 (en) * 2020-10-02 2024-10-02 Eagle Harbor Technologies, Inc. IONIC CURRENT DROP COMPENSATION
WO2022165424A1 (en) 2021-02-01 2022-08-04 Inventure, LLC Synthesis methods and compositions of low intermediate and low dichelate intermediate contrast agents
KR102845061B1 (ko) * 2022-09-01 2025-08-13 주식회사 테라노큐어 신규한 화합물 및 이를 포함하는 mri 조영제
JP7895667B2 (ja) * 2022-09-01 2026-07-28 テラノキュア カンパニー リミテッド 新規化合物、およびこれを含むｍｒｉ造影剤
WO2026027591A1 (en) 2024-07-31 2026-02-05 Bracco Imaging Spa Synthesis of an intermediate of a gadolinium-based contrast agent

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112533921A (zh) * 2018-08-06 2021-03-19 伯拉考成像股份公司 基于带有钆的pcta的造影剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647447A (en) 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3640708C2 (de) 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
DE4001655A1 (de) 1990-01-18 1991-07-25 Schering Ag 6-ring enthaltende makrocyclische tetraaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
JPH04154729A (ja) 1990-10-16 1992-05-27 Nippon Mejifuijitsukusu Kk 磁気共鳴造影剤
IT1292128B1 (it) 1997-06-11 1999-01-25 Bracco Spa Processo per la preparazione di chelanti macrociclici e loro chelati con ioni metallici paramagnetici
EP0992245A1 (en) 1998-09-16 2000-04-12 Goldham Bioglan Pharma GmbH Radio-contrast agents
FR2793795B1 (fr) * 1999-05-21 2001-08-03 Guerbet Sa Isomeres de tetramides du complexe de gadolinium de l'acide (1,4,7,10-tetrazacyclododecane)1,4,7,10-tetra(2-glutarique) leur procede de preparation et leur application en imagerie medicale
FR2794744B1 (fr) 1999-06-09 2001-09-21 Guerbet Sa Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale
FR2891830B1 (fr) * 2005-10-07 2011-06-24 Guerbet Sa Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale
US20090208421A1 (en) * 2008-02-19 2009-08-20 Dominique Meyer Process for preparing a pharmaceutical formulation of contrast agents
US8119817B2 (en) * 2009-09-29 2012-02-21 Degussa-Huels Ag Process for separating the diastereomers of RSS-and SSS-N- α [1-carboxy-3-phenylpropyl] lysylproline
EP2786768A1 (en) 2013-04-04 2014-10-08 Agfa Healthcare Process for preparing a material comprising a macrocyclic ligand and for producing a pharmaceutical formulation comprising said ligand with a lanthanide
KR102231121B1 (ko) * 2013-04-26 2021-03-23 게르브 조영제 제형 및 이와 관련된 제조 방법
CN104188957B (zh) * 2014-05-28 2017-04-26 中国中医科学院西苑医院 一种防治再狭窄的药物及其制备和使用方法
US11155519B2 (en) * 2017-04-28 2021-10-26 Otsuka Pharmaceutical Factory, Inc. Method for manufacturing diastereomer of citric acid derivative
FR3091873B1 (fr) 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
FR3091872B1 (fr) 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112533921A (zh) * 2018-08-06 2021-03-19 伯拉考成像股份公司 基于带有钆的pcta的造影剂

Also Published As

Publication number Publication date
EP3902800A1 (fr) 2021-11-03
FR3091873B1 (fr) 2020-12-25
CA3126268C (fr) 2024-01-09
JP7071596B2 (ja) 2022-05-19
MA54626A (fr) 2022-04-20
PH12021551725A1 (en) 2022-04-11
KR20210138134A (ko) 2021-11-18
KR102438394B1 (ko) 2022-09-01
US12064487B2 (en) 2024-08-20
US11590246B2 (en) 2023-02-28
HRP20230678T1 (hr) 2023-09-29
IL284884A (en) 2021-08-31
TWI811518B (zh) 2023-08-11
EP3943493B1 (fr) 2023-04-19
HUE062554T2 (hu) 2023-11-28
HUE060343T2 (hu) 2023-02-28
RS64334B1 (sr) 2023-08-31
JP2022508496A (ja) 2022-01-19
WO2020148436A1 (fr) 2020-07-23
ES2950118T3 (es) 2023-10-05
TW202043227A (zh) 2020-12-01
CN113735854A (zh) 2021-12-03
PT3902800T (pt) 2022-11-16
DK3902800T3 (da) 2022-11-28
ZA202104994B (en) 2023-04-26
FI3943493T3 (fi) 2023-07-19
MX2021008651A (es) 2021-10-26
CN113735854B (zh) 2024-05-14
SG11202107779SA (en) 2021-08-30
PL3902800T3 (pl) 2022-12-27
AU2020208794A1 (en) 2021-08-05
KR20210109039A (ko) 2021-09-03
US20240358863A1 (en) 2024-10-31
EP3943493A1 (fr) 2022-01-26
JP2022009463A (ja) 2022-01-14
HRP20221402T1 (hr) 2023-01-06
MA55389A (fr) 2022-01-26
AU2020208794B2 (en) 2023-01-12
PL3943493T3 (pl) 2023-08-07
IL284884B2 (en) 2025-09-01
US20220062443A1 (en) 2022-03-03
CN119552163A (zh) 2025-03-04
CO2021009261A2 (es) 2021-12-10
BR112021014006A2 (pt) 2021-09-21
FR3091873A1 (fr) 2020-07-24
CA3126268A1 (fr) 2020-07-23
DK3943493T3 (da) 2023-07-24
IL284884B1 (en) 2025-05-01
BR112021014006B1 (pt) 2023-05-02
CN113646308A (zh) 2021-11-12
CL2021001868A1 (es) 2022-01-21
KR102502862B1 (ko) 2023-02-23
ES2930136T3 (es) 2022-12-07
US20230149568A1 (en) 2023-05-18
PT3943493T (pt) 2023-07-12
AR117835A1 (es) 2021-08-25
EP3902800B1 (fr) 2022-09-07
JP7321230B2 (ja) 2023-08-04

Similar Documents

Publication Publication Date Title
CN116209661B (zh) 用于制备基于pcta的螯合配体的方法
CN119552163A (zh) 钆和基于非对映异构体富集的pcta的螯合配体的络合物及其制备和纯化方法
CN113646309B (zh) 钆和基于pcta的螯合配体的非对映异构体富集的络合物和合成方法
US11370804B2 (en) Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched PCTA and preparation and purification process
HK40062827A (en) Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched pcta and preparation and purification process
RU2806027C2 (ru) Диастереоизомерно обогащенный комплекс гадолиния и хелатирующего лиганда на основе pcta, способ его получения и очистки
HK40119100A (en) Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched pcta and preparation and purification process thereof
HK40062154A (en) Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched pcta and preparation and purification process
HK40063372B (en) Complex of gadolinium and a chelating ligand derived from diastereoisomerically enriched pcta and method for preparing and purifying same
HK40062828B (en) Complex of gadolinium and a chelating ligand derived of a diastereoisomerically enriched pcta and synthesis method
HK40062828A (en) Complex of gadolinium and a chelating ligand derived of a diastereoisomerically enriched pcta and synthesis method
HK40062157B (en) Complex of gadolinium and a chelating ligand derived of a diastereoisomerically enriched pcta and synthesis method
HK40062157A (en) Complex of gadolinium and a chelating ligand derived of a diastereoisomerically enriched pcta and synthesis method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40062154

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant